How an innovative digital platform supports precision medicine

Precision Medicine: Advances and Challenges in Drug Development

Medicine is constantly evolving and increasingly offers personalized treatments that are tailored to individual medical conditions, such as cancer. These precision approaches promise optimized chances of recovery, but face major challenges in practical implementation. A core problem is the often inadequate testing of new drugs. Many patients suffer from incorrect medications which, in the best case, remain ineffective, but often increase side effects or have long-term consequences.

Experts emphasize that when a new drug is launched on the market, it is often necessary to treat between 3 and 25 patients before a patient actually benefits from it. The need to reduce the number of unnecessary medications is therefore urgent. Traditional pharmacovigilance systems are not sufficient to reliably assess the safety and effectiveness of new drugs.

The classic drug review process includes the evaluation of case studies and expert opinions, followed by controlled and randomized controlled trials (RCTs). However, an additional step is required to exploit the full potential of precision medicine: After approval, the effects and side effects of a drug must be comprehensively documented and analyzed. This is the only way to ensure the safety and effectiveness of treatment for each individual patient. This is exactly where XO Life comes in and supports precision medicine.